{"name":"Medtronic","slug":"medtronic","ticker":"MDT","exchange":"NYSE","domain":"medtronic.com","description":"Medtronic plc is an American-Irish medical device company. The company's legal and executive headquarters are in Ireland, while its operational headquarters are in Minneapolis, Minnesota. Medtronic rebased to Ireland following its acquisition of Irish-based Covidien in 2015. While it primarily operates in the United States, it operates in more than 150 countries and employs over 90,000 people. It develops and manufactures healthcare technologies and therapies. It is one of the biggest medical tech companies in the world and is currently the largest medical device company in the world by revenue.","hq":"Dublin, Ireland / Minneapolis, MN","founded":1949,"employees":"95000","ceo":"Geoff Martha","sector":"Medical Devices","stockPrice":76.76,"stockChange":0.55,"stockChangePercent":0.72,"marketCap":"$98.6B","metrics":{"revenue":35484000256,"revenueGrowth":8.7,"grossMargin":65.2,"rdSpend":0,"netIncome":4662000000,"cash":8383000064,"dividendYield":3.73,"peRatio":21.4,"fiscalYear":"FY2025"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2025-06-01","label":"Infinion patent cliff ($1.2B at risk)","drug":"Infinion","type":"patent_expiry","sentiment":"negative"},{"date":"2026-06-01","label":"Guardant patent cliff ($500M at risk)","drug":"Guardant","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"oncology","drugs":[{"name":"Senna tablets","genericName":"Senna tablets","slug":"senna-tablets","indication":"Constipation","status":"marketed"},{"name":"Inductos","genericName":"DIBOTERMIN ALFA","slug":"dibotermin-alfa","indication":"Degeneration of intervertebral disc","status":"marketed"},{"name":"Thienopyridine Therapy","genericName":"Thienopyridine Therapy","slug":"thienopyridine-therapy","indication":"Other","status":"marketed"},{"name":"intrathecal baclofen","genericName":"intrathecal baclofen","slug":"intrathecal-baclofen","indication":"Other","status":"marketed"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"immunology","drugs":[{"name":"Flecainide or Sotalol or Propafenone","genericName":"Flecainide or Sotalol or Propafenone","slug":"flecainide-or-sotalol-or-propafenone","indication":"Atrial fibrillation (maintenance of sinus rhythm or rate control)","status":"phase_3"},{"name":"Antiarrhythmic Drugs","genericName":"Antiarrhythmic Drugs","slug":"antiarrhythmic-drugs","indication":"Atrial fibrillation","status":"marketed"},{"name":"Diuretic Increase (DI)","genericName":"Diuretic Increase (DI)","slug":"diuretic-increase-di","indication":"Heart failure with fluid overload (presumed, based on diuretic enhancement indication)","status":"marketed"},{"name":"Diuretic Suspension (DS)","genericName":"Diuretic Suspension (DS)","slug":"diuretic-suspension-ds","indication":"Edema associated with congestive heart failure","status":"marketed"}]}],"pipeline":[{"name":"Senna tablets","genericName":"Senna tablets","slug":"senna-tablets","phase":"marketed","mechanism":"Senna stimulates colonic muscle contractions and increases intestinal fluid secretion to promote bowel movements.","indications":["Constipation","Bowel evacuation before diagnostic procedures"],"catalyst":""},{"name":"Flecainide or Sotalol or Propafenone","genericName":"Flecainide or Sotalol or Propafenone","slug":"flecainide-or-sotalol-or-propafenone","phase":"phase_3","mechanism":"These antiarrhythmic drugs suppress abnormal heart rhythms by blocking sodium and/or potassium channels in cardiac tissue, slowing electrical conduction and prolonging the refractory period.","indications":["Atrial fibrillation (maintenance of sinus rhythm or rate control)","Paroxysmal supraventricular tachycardia","Ventricular arrhythmias","Prevention of arrhythmia recurrence in patients with implantable cardioverter-defibrillators"],"catalyst":""},{"name":"Antiarrhythmic Drugs","genericName":"Antiarrhythmic Drugs","slug":"antiarrhythmic-drugs","phase":"marketed","mechanism":"Antiarrhythmic drugs work by modulating cardiac electrical conduction to restore and maintain normal heart rhythm.","indications":["Atrial fibrillation","Ventricular arrhythmias","Supraventricular tachycardia","Arrhythmia prevention post-ablation"],"catalyst":""},{"name":"Diuretic Increase (DI)","genericName":"Diuretic Increase (DI)","slug":"diuretic-increase-di","phase":"marketed","mechanism":"Diuretic Increase (DI) is a device-based therapy from Medtronic that enhances diuretic efficacy, likely through optimized drug delivery or physiological modulation to increase urine output.","indications":["Heart failure with fluid overload (presumed, based on diuretic enhancement indication)"],"catalyst":""},{"name":"Diuretic Suspension (DS)","genericName":"Diuretic Suspension (DS)","slug":"diuretic-suspension-ds","phase":"marketed","mechanism":"Diuretic Suspension promotes fluid and electrolyte excretion through the kidneys to reduce fluid overload and blood pressure.","indications":["Edema associated with congestive heart failure","Hypertension","Fluid overload"],"catalyst":""},{"name":"Inductos","genericName":"DIBOTERMIN ALFA","slug":"dibotermin-alfa","phase":"marketed","mechanism":"Recombinant protein","indications":["Degeneration of intervertebral disc","Fracture of tibia"],"catalyst":""},{"name":"Thienopyridine Therapy","genericName":"Thienopyridine Therapy","slug":"thienopyridine-therapy","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"intrathecal baclofen","genericName":"intrathecal baclofen","slug":"intrathecal-baclofen","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[{"date":"2024-02-22","type":"earnings","headline":"Medtronic Reports Fourth-Quarter and Full-Year 2023 Financial Results","summary":"Medtronic reported fourth-quarter and full-year 2023 financial results, with revenue of $8.4 billion and adjusted earnings per share of $1.21.","drugName":"","sentiment":"neutral"},{"date":"2023-09-22","type":"deal","headline":"Medtronic Acquires Digital Health Company, Nutrino Health","summary":"Medtronic acquired digital health company, Nutrino Health, to expand its capabilities in the digital health space.","drugName":"","sentiment":"positive"},{"date":"2023-06-30","type":"regulatory","headline":"FDA Approves Medtronic's Intellis Spinal Cord Stimulation System","summary":"The FDA approved Medtronic's Intellis Spinal Cord Stimulation System for the treatment of chronic pain.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxOcUdwX1paN1FNdTV3VjhBM1N1ejdQYkNhaENERHJkb3BvM1Q5NHBfbnFNNERUT1RsRm9SRUZiczg1ODd4TUJpSEExSVhFc2w1cFB5MmViSEZnNThiNVlnS3pjYUpkdkhSamlvRlBXNEQ2S3d6TjRVVWt0WjlHTFExT2lPSzRRU25LSVczb3VaSTBLb0ExMmhYblJrMGw4Wk9kc3NsZ2xDZEZQaDhXXzEyamlTXzZNMmtCMmdhR3ZHenpRc1YzNjFuSUhBdzVzaFRyZzhpc0NR?oc=5","date":"2026-03-27","type":"regulatory","source":"Reuters","summary":"Medtronic gets US FDA nod to use surgical system in cranial, ENT surgeries - Reuters","headline":"Medtronic gets US FDA nod to use surgical system in cranial, ENT surgeries","sentiment":"neutral"},{"date":"2026-03-24","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxOa2FGbVA3SF9ZdU1yTng1Q2lCYzdOSzlRSVVqLWJpdk4tTjNkbWhCUkZjNDBYWWY5SlFJRU15MC1hSkt1V1pxUjRRTjRWdkZtZUpBenptYWF1UUV4QmdXN1BlSi00X2dDTHdma2QxTjhnVHRrekozOFJsWlFNVVNwMGFHTXRjR1NxM20yaThsMm1uNHct?oc=5","date":"2026-03-05","type":"deal","source":"The Motley Fool","summary":"2 Top Healthcare Dividend Stocks to Buy and Hold Forever - The Motley Fool","headline":"2 Top Healthcare Dividend Stocks to Buy and Hold Forever","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxPY0hGLWVJVkxFc3BoSHVyb3lHbG9GZm42R1FnNUE5eUk1UjlrelNCMnJLVFl3YjcteEFSc3RDTk1GaXFYb3dxaHVsZmhmVXcyQUJDRlgtZy1CNHVPT3NiZ0ItdW40QWlXT0RTVmZ0ajJJcUlEQlZZbWtUQWkyZUlGWTEwMm8xM25mRmYwLTJwdXRxQzhJbEQxTTQ0NUZPY1NQUjNMTDlmYVdQVTZkSmUwVjdUZTdobmIySlpXVQ?oc=5","date":"2026-02-24","type":"pipeline","source":"Reuters","summary":"Medtronic's diabetes unit MiniMed eyes $7.9 billion valuation in US IPO - Reuters","headline":"Medtronic's diabetes unit MiniMed eyes $7.9 billion valuation in US IPO","sentiment":"neutral"},{"date":"2026-02-24","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: 10-Q","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2gFBVV95cUxORFZTN3lmSVRZcnVITTJ2VzEwQm1oZHhTSENTbVJlUGd0aEhxeV9RbXFrNTJFMTYwVnRBa21SQko5aVJ0RGc2azBrRkJ4RWl5SXRJN1VMbDB5VUF3MXhVdzFtaDQyc3BnU2Z6eG5tQV82QkhZTGwxaERWdFlEZkkwdU5ZSmxhZ0lZUVBybEVKMkU3WDc5X2JQSU1lMklsOWp6V1FmNTk0TGVRQUNScVlCY3RaMXg5WDNyZVU2d3lzY1U3M294VndsNXZqZ2c2UVRWWHllMy0tR0gzdw?oc=5","date":"2026-02-17","type":"earnings","source":"Reuters","summary":"Medtronic's unchanged annual outlook clouds upbeat quarterly results - Reuters","headline":"Medtronic's unchanged annual outlook clouds upbeat quarterly results","sentiment":"positive"},{"date":"2026-02-17","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxPejE5bks5NFNjb0VmY2I5eXZDakZqUEN6d1QwR3pvSnpCNkRHUE5vcWxudThMY2laSUdwZUd3dzNLNFJrdk52dnNWdFg1VWRQR2tNanJsYm9fNkxMdjNvLUR1SFI4aWRVMkZhdW80Q2dHWEpWMTR4dXEwNWdsZVRXX2ptak1wTzJoTjhhNW15c3hEUWRWc2hj?oc=5","date":"2026-01-09","type":"pipeline","source":"The Motley Fool","summary":"Prediction: 2 Healthcare Stocks That Will Be Worth More Than Pfizer by the End of 2026 - The Motley Fool","headline":"Prediction: 2 Healthcare Stocks That Will Be Worth More Than Pfizer by the End of 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxNZFhJQjVIaDkwS0gzWVV6Z2NZRFFVbzBISDZ0YnVqek5tc2xFUVgwNlRIbmlZZl9TamNzOWFucUJsZ0xDY1ZCdzlMNmJIUTFoeUVNWS1YT1dHRHIySmF2OEc1NVpxWk5IMUFXSmt1YlFLYmlYZjltbFpfckV2R0MxQjRjRDBESHJENUJCTA?oc=5","date":"2026-01-07","type":"pipeline","source":"Drug Delivery Business","summary":"Medtronic expands US pharmacy formulary access for MiniMed 780G - Drug Delivery Business","headline":"Medtronic expands US pharmacy formulary access for MiniMed 780G","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTE1SLUtGTW5vM1JsbktCUjBLemxGdG80Mi1WemI5VHg1MF9lTFdaX3k0d3dfd3BiWGRBZEdKd0xHd2RKa29KYlFKSFh3ZWpINjlNRG5hazlBN0t1Rlc5eHF2Uk4zbXFwaER5eE5DQ3lsdkZ2bGE2eU9vVUVRNEVCZlU?oc=5","date":"2026-01-07","type":"pipeline","source":"MassDevice","summary":"Medtronic expands US pharmacy formulary access for MiniMed 780G - MassDevice","headline":"Medtronic expands US pharmacy formulary access for MiniMed 780G","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTE4wWWxFWEowUlVLWEZmVVMzdkM4WUM5MGtjRW5UcW9kR2JJa1Q3TExEeUVzVGFYUDFyV01VSWk5eUd3eHAzY1NUc3paZWR3cl9EVlNRdDRSM2tIOFo1QzNvSDdna3BwMHlOSDZtVGpjcmR5QlV3VWNZYkJseVg2aUE?oc=5","date":"2026-01-06","type":"pipeline","source":"Yahoo Finance","summary":"The Zacks Analyst Blog Eli Lilly, Medtronic, Intuitive Surgical, Regeneron Pharmaceuticals and Johnson & Johnson - Yahoo Finance","headline":"The Zacks Analyst Blog Eli Lilly, Medtronic, Intuitive Surgical, Regeneron Pharmaceuticals and Johnson & Johnson","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxQLTNPXzlwQ19tUVBOS2pyNjRrdjVIRWRjLWVZUlhYX1k1T1Vvc2k1cmtfc2FvclVkX1FyZWhnOWYtM3o4SUpoTmZ3MnR3eDJuQ2dkS2EtUlV4UW5sUWFISEViWThvZ0RzbUNxQ2I3TnBiY2xFekpvaHNtU2UwOWxoX3BLejZteFFha0J2bHpmVE42dXR4QTZUWVl1cEpYQVVsWEFidzlGYnFmaFE?oc=5","date":"2025-12-24","type":"pipeline","source":"NAI500","summary":"Looking for a “Forever” Stock? These 2 Healthcare Picks Are Worth Considering - NAI500","headline":"Looking for a “Forever” Stock? These 2 Healthcare Picks Are Worth Considering - NAI500","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxObUxLSS1JMUVEdkdvOGlyVWFkS1ZaMmJvdWhzTXNPX0NTT0FiRU1yZ3dBcXdMcm51ZnVuX2J1emhTSXB6d1Q4SkRMc0lnZlEyX1dhU2xiVmhRVFlGcU5zN3UwZ0JYZzB6UUc4cWRtZzFVSFRETzVjano0NzBCaGRtYnc0NmlDdmhuRUF5UGdlZ19iU2pLRU5Z?oc=5","date":"2025-10-27","type":"deal","source":"The Motley Fool","summary":"2 Unstoppable Health Care Giants to Buy Right Now for Less Than $1,000 - The Motley Fool","headline":"2 Unstoppable Health Care Giants to Buy Right Now for Less Than $1,000","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwJBVV95cUxQcUpJUGRrUlZpQVJhWUctMWNlR2FGZFdGRTVtSUsteGlJYWR3TXRoeU1rb2s4a2ZmeUtIdHBReEZBcUpZUDA2UWsxRGxlenU3dy1tQl9QNjN6UXF0WUNQQnBfZEpEMEJIWi0yU1pKN3FFekp6SDdlWW9wbG4zbUtDeFNsQ0ZPX0d2cXV2amVhSlVDNlRWZy1IMDhxUVp1bzNrUFdGU0F6emNRYzZIQkswbjEwa21GcjhybGgxZ2NmX3ltN2tqd2drbTRmNlJqZW1Tay1wNlRGNmZPWjFEekJtdUU1ZDlCdm8ydjJMQk8xSmNsY2MtU0s4ai1iQVpNXzFhbnR6d3RfOTlpNnZibWNTbjFYaw?oc=5","date":"2025-10-15","type":"pipeline","source":"The Globe and Mail","summary":"Analysts Conflicted on These Healthcare Names: Avidity Biosciences (RNA), Medtronic (MDT) and Pfizer (PFE) - The Globe and Mail","headline":"Analysts Conflicted on These Healthcare Names: Avidity Biosciences (RNA), Medtronic (MDT) and Pfizer (PFE)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxPTDkyQVIwUGh2aGxzbkdvamw1Y1U5ZFhrVFlzOGxJeWxQaWlaR0NUelZVWmFvOG1qUDhrbm9ZaExlMVlpczhRX0tnV1Z6aDFLaUdENjlaTDUyLWVCMkF6VFlmRTJMNkRHODU1bWtXM2NoZW9KdTZlTEZuc1VIem53UGpMcC1ybTBtUm9fMlVTYUlleUhZQnJQSko1WVlMdDQzX0FMUC15Y1E4UFE3d0s4T1ZsWC1oQjBpalVocE9R?oc=5","date":"2023-12-11","type":"pipeline","source":"PR Newswire","summary":"Medtronic and Cosmo Pharmaceuticals forge ahead in AI-driven care - PR Newswire","headline":"Medtronic and Cosmo Pharmaceuticals forge ahead in AI-driven care","sentiment":"neutral"}],"patents":[{"drugName":"Infinion","drugSlug":"infinion","patentNumber":"","type":"Patent Cliff","expiryDate":"2025-06-01","territory":"US","annualRevenue":1200000000},{"drugName":"Guardant","drugSlug":"guardant","patentNumber":"","type":"Patent Cliff","expiryDate":"2026-06-01","territory":"US","annualRevenue":500000000}],"drugCount":8,"phaseCounts":{"marketed":7,"phase_3":1},"enrichmentLevel":3,"visitCount":2,"keyCompetitors":["Abbott Laboratories (ABT)","Boston Scientific Corporation (BSX)","Stryker Corporation (SYK)"],"therapeuticFocus":["Cardiovascular","Neurological","Spinal"],"financials":{"source":"sec_edgar+yahoo","revenue":33537000000,"revenuePeriod":"2025-04-25","revenueHistory":[{"value":33537000000,"period":"2025-04-25"},{"value":32364000000,"period":"2024-04-26"},{"value":32364000000,"period":"2024-04-26"},{"value":31227000000,"period":"2023-04-28"},{"value":31227000000,"period":"2023-04-28"}],"grossProfit":21905000000,"grossProfitHistory":[{"period":"2025-04-30","value":21905000000},{"period":"2024-04-30","value":21148000000},{"period":"2023-04-30","value":20508000000},{"period":"2022-04-30","value":21541000000}],"rdSpend":2732000000,"rdSpendHistory":[{"period":"2025-04-30","value":2732000000},{"period":"2024-04-30","value":2735000000},{"period":"2023-04-30","value":2696000000},{"period":"2022-04-30","value":2746000000}],"sgaSpend":10849000000,"operatingIncome":6540000000,"operatingIncomeHistory":[{"period":"2025-04-30","value":6540000000},{"period":"2024-04-30","value":5520000000},{"period":"2023-04-30","value":5830000000},{"period":"2022-04-30","value":5908000000}],"netIncome":4662000000,"netIncomeHistory":[{"period":"2025-04-30","value":4662000000},{"period":"2024-04-30","value":3676000000},{"period":"2023-04-30","value":3758000000},{"period":"2022-04-30","value":5039000000}],"eps":3.61,"epsHistory":[{"period":"2025-04-30","value":3.61},{"period":"2024-04-30","value":2.76},{"period":"2023-04-30","value":2.82},{"period":"2022-04-30","value":3.73}],"cash":2218000000,"cashHistory":[{"period":"2025-04-30","value":2218000000},{"period":"2024-04-30","value":1284000000},{"period":"2023-04-30","value":1543000000},{"period":"2022-04-30","value":3714000000}],"totalAssets":91680000000,"totalLiabilities":43424000000,"totalDebt":28516000000,"equity":48024000000,"operatingCashflow":7044000000,"operatingCashflowHistory":[{"period":"2025-04-30","value":7044000000},{"period":"2024-04-30","value":6787000000},{"period":"2023-04-30","value":6039000000},{"period":"2022-04-30","value":7346000000}],"capex":-1859000000,"capexHistory":[{"period":"2025-04-30","value":-1859000000},{"period":"2024-04-30","value":-1587000000},{"period":"2023-04-30","value":-1459000000},{"period":"2022-04-30","value":-1368000000}],"freeCashflow":5185000000,"dividendsPaid":-3589000000,"buybacks":-3235000000,"employees":95000,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[{"sga":2956000000,"ebit":1585000000,"ebitda":2334000000,"period":"2026-01-31","revenue":9017000000,"epsBasic":0.89,"netIncome":1143000000,"rdExpense":722000000,"epsDiluted":0.89,"grossProfit":5756000000,"operatingIncome":1602000000},{"sga":2965000000,"ebit":1778000000,"ebitda":2523000000,"period":"2025-10-31","revenue":8961000000,"epsBasic":1.07,"netIncome":1374000000,"rdExpense":754000000,"epsDiluted":1.07,"grossProfit":5900000000,"operatingIncome":1696000000},{"sga":2806000000,"ebit":1478000000,"ebitda":2226000000,"period":"2025-07-31","revenue":8578000000,"epsBasic":0.81,"netIncome":1040000000,"rdExpense":726000000,"epsDiluted":0.81,"grossProfit":5577000000,"operatingIncome":1516000000},{"sga":2720000000,"ebit":1435000000,"ebitda":2275000000,"period":"2025-04-30","revenue":8927000000,"epsBasic":0.82,"netIncome":1056000000,"rdExpense":684000000,"epsDiluted":0.82,"grossProfit":5780000000,"operatingIncome":1797000000},{"sga":2717000000,"ebit":1719000000,"ebitda":2403000000,"period":"2025-01-31","revenue":8292000000,"epsBasic":1.01,"netIncome":1294000000,"rdExpense":675000000,"epsDiluted":1.01,"grossProfit":5513000000,"operatingIncome":1710000000}]},"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":76.76,"previousClose":76.21,"fiftyTwoWeekHigh":106.33,"fiftyTwoWeekLow":74.4,"fiftyTwoWeekRange":"74.4 - 106.33","fiftyDayAverage":85.04,"twoHundredDayAverage":93.59,"beta":0.63,"enterpriseValue":117743869952,"forwardPE":12.7,"priceToBook":2.01,"priceToSales":2.78,"enterpriseToRevenue":3.32,"enterpriseToEbitda":12.47,"pegRatio":1.33,"ebitda":9440000000,"ebitdaMargin":26.6,"freeCashflow":4073125120,"operatingCashflow":7285000192,"totalDebt":28071000064,"debtToEquity":57.1,"currentRatio":2.54,"returnOnAssets":4.6,"returnOnEquity":9.4,"analystRating":"","recommendationKey":"none","numberOfAnalysts":25,"targetMeanPrice":108,"targetHighPrice":121,"targetLowPrice":90,"dividendRate":2.84,"payoutRatio":0.79,"fiveYearAvgDividendYield":2.97,"exDividendDate":1774569600,"insiderHeldPercent":0.3,"institutionHeldPercent":89.8,"sharesOutstanding":1283884964,"floatShares":1281573971,"sharesShort":14604547,"shortRatio":1.7,"shortPercentOfFloat":1.1,"epsTrailing":3.58,"epsForward":6.06,"revenuePerShare":27.68,"bookValue":38.17,"officers":[{"age":55,"name":"Mr. Geoffrey Straub Martha","title":"Chairman of the Board & CEO"},{"age":55,"name":"Mr. Thierry  Pieton","title":"Executive VP & CFO"},{"age":59,"name":"Mr. Brett A. Wall","title":"Executive VP & President of Neuroscience Portfolio"},{"age":null,"name":"Mr. Mark  Ploof","title":"Senior Vice President of Global Operations and Business Services"},{"age":null,"name":"Ms. Denise L. Blomquist","title":"VP, Global Controller & Chief Accounting Officer"},{"age":55,"name":"Dr. Laura  Mauri M.D., M.Sc.","title":"Senior VP and Chief Scientific & Medical Officer"},{"age":null,"name":"Ms. Ingrid  Goldberg","title":"Vice President & Head of Investor Relations"},{"age":56,"name":"Ms. Michelle  Quinn","title":"Executive VP, General Counsel & Secretary"}],"industry":"Medical Devices","irWebsite":"","website":"https://www.medtronic.com","phone":"353 1 438 1700"}}